Abstract # 1117 Combined 18FDG PET-CT Before Radiotherapy May Predict Survival In Patients With A Glioblastoma

Presenter: Baumert, Brigitta

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

About the Presenter:
Brigitta G. Baumert, MD, PhD, is a staff member in the Department of Radiation Oncology (MAASTRO) at the University Hospital Maastricht in The Netherlands. Dr. Baumert earned her Medical Degree at Albert-Ludwigs-Universitat, Freiburg, Germany. She trained in radiation oncology in Switzerland. For her specialization in neuro-oncology and stereotactic radiotherapy, she later spent time as a research fellow at the Royal Marsden Hospital in London, England. Brigitta Baumert is an active investigator in the area of stereotactic radiotherapy and neuro-oncology. She is the principal investigator of the EORTC joint trial with the ROG, BTG, and NCI-Canada on the treatment of patients with low-grade glioma. Other areas of interest are technical developments such as intensity-modulated radiotherapy and new diagnostic imaging tools (eg, PET-CT for radiation oncology).
Contact the presenter at: brigitta.baumert@maastro.nl

Authors:
B. G. Baumert*1, B. Vanhauten*1, S. B. Abdulfatah*2, R. Houben*1, R. Debougnoux-Huppertz*1, M. van Kroonenburgh*2, G. Bosmans*1, P. Lambin*1. , 1Dept Radiation-Oncology (MAASTRO), GROW, University Hospital Maastricht, Maastricht, The Netherlands, 2Dept Nuclear Medicine, University Hospital Maastricht, Maastricht, The Netherlands,

Author Disclosure:
B.G. Baumert, None; B. Vanhauten, None; S.B. Abdulfatah, None; R. Houben, None; R. Debougnoux-Huppertz, None; M. van Kroonenburgh, None; G. Bosmans, None; P. Lambin, None.


E-mail a friend about this abstract:
Enter email address:   



Abstracts Main Page | Logout